ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
SELLAS Achieves Immune Response Data in Triple Negative Breast Cancer
June 20, 2019NPS-Specific Cytotoxic T-Lymphocyte mean frequencies increased by 2.86-fold compared to Baseline at 30 months. -
Galena Biopharma merges SELLAS to form new combined company
August 11, 2017SELLAS is a privately held, oncology-focused, clinical stage biopharmaceutical company. The newly formed company will feature a late-stage pipeline focusing on the development of new immunotherapies targeting a wide range of indications in haematology an
Pharma Sources Insight January 2025
